[ad_1]
- Entegris, Inc ENTG reported second-quarter FY22 gross sales progress of 21% year-on-year to $692.5 million, beating the consensus of $666.6 million.
- Income from Specialty Chemical compounds and Engineered Supplies phase rose 15.2% Y/Y to $207.7 million; Microcontamination Management expanded 20.5% Y/Y to $274.1 million; Superior Supplies Dealing with improved 29.9% Y/Y to $224.1 million.
- Margins: The adjusted gross margin contracted 160 foundation factors to 44.8%, and the adjusted working margin was flattish at 26.4%.
- The non-GAAP EPS of $1.00 missed the consensus of $1.05.
- Entegris generated $110.9 million in working money movement and held $2.7 billion in money and equivalents.
- CEO Bertrand Loy stated: “Gross sales progress and operational execution had been as soon as once more very sturdy within the second quarter. Progress was vital throughout all three divisions, pushed by demand for our options and nice execution by our provide chain groups. Particularly, we noticed sturdy exercise on the superior nodes, the place we get pleasure from larger Entegris content material per wafer. Non-GAAP EPS was barely beneath our expectations within the second quarter, primarily as a result of a major decline in just a few main currencies versus the U.S. Greenback.”
- Outlook: Entegris sees Q3 gross sales of $1.zero billion – $1.04 billion, above the consensus of $811.2 million.
- Worth Motion: ENTG shares traded decrease by 3.18% at $106.98 on the final verify Tuesday.
© 2022 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
[ad_2]
Supply hyperlink